Tetrachlorophthalic anhydride asthma: Evidence for specific IgE antibody

Tetrachlorophthalic anhydride asthma: Evidence for specific IgE antibody

Pokaż inne wersje (2)

Opis bibliograficzny
Główni autorzy:	Venables, K, Topping, M, Howe, W
Format:	Journal article
Język:	English
Wydane:	1982

Podobne zapisy

Tetrachlorophthalic anhydride asthma: evidence for specific IgE antibody.
od: Howe, W, i wsp.
Wydane: (1983)

Tetrachlorophthalic anhydride asthma: evidence for specific IgE antibody
od: Howe, W, i wsp.
Wydane: (1983)

Exposure-response relationships in asthma caused by tetrachlorophthalic anhydride
od: Venables, K, i wsp.
Wydane: (1990)

Exposure-response relationships in asthma caused by tetrachlorophthalic anhydride.
od: Venables, K, i wsp.
Wydane: (1990)

Specificity of the human IgE response to inhaled acid anhydrides.
od: Topping, MD, i wsp.
Wydane: (1986)

Immunologic and functional consequences of chemical (tetrachlorophthalic anhydride)-induced asthma after four years of avoidance of exposure.
od: Venables, K, i wsp.
Wydane: (1987)

Occupational asthma caused by tetrachlorophthalic anhydride: A 12-year follow-up
od: Barker, R, i wsp.
Wydane: (1998)

Occupational asthma caused by tetrachlorophthalic anhydride: a 12-year follow-up.
od: Barker, R, i wsp.
Wydane: (1998)

Immunologic and functional consequences of chemical (tetrachlorophthalic anhydride)-induced asthma after four years of avoidance of exposure
od: Venables, K
Wydane: (1987)

Interaction of smoking and atopy in producing specific IgE antibody against a hapten protein conjugate.
od: Venables, K, i wsp.
Wydane: (1985)

Acid anhydrides and asthma.
od: Taylor, A, i wsp.
Wydane: (1987)

Trimellitic anhydride induces low-grade mast cell degranulation without specific IgE
od: Kazuhiro Ogi, M.D., Ph.D, i wsp.
Wydane: (2016-01-01)

Relevance of serum specific IgE and total IgE estimation in asthma patients with pigeon exposure
od: Anil Kumar Mavi, i wsp.
Wydane: (2020-08-01)

Comprehensive analysis of allergen-specific IgE in COPD: mite-specific IgE specifically related to the diagnosis of asthma-COPD overlap
od: Hikaru Toyota, i wsp.
Wydane: (2021-02-01)

Detection of specific IgE antibodies in parasite diseases
od: M.L.B. Souza-Atta, i wsp.
Wydane: (1999-09-01)

Specific IgE Response and Omalizumab Responsiveness in Severe Allergic Asthma
od: Tajiri T, i wsp.
Wydane: (2023-01-01)

Levels of total IgE versus specific IgE during childhood for defining and predicting T2-high asthma
od: Tamo Sultan, MD, i wsp.
Wydane: (2024-12-01)

Anti-IgE therapy for IgE-mediated allergic diseases: from neutralizing IgE antibodies to eliminating IgE+ B cells
od: Jiayun Hu, i wsp.
Wydane: (2018-07-01)

Atopy and Multisensitizations in Specific IgE Microarrays and Their Impact on Severe Asthma
od: Jan Romantowski, i wsp.
Wydane: (2022-09-01)

Cumulative IgE-levels specific for respiratory allergens as biomarker to predict efficacy of anti-IgE-based treatment of severe asthma
od: Veronika Naumova, i wsp.
Wydane: (2022-09-01)

Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity.
od: David L Hahn, i wsp.
Wydane: (2012-01-01)

Anti-IgE for asthma in inner-city children.
od: Pavord, I, i wsp.
Wydane: (2011)

Anti-IgE for asthma in inner-city children
od: Pavord, I, i wsp.
Wydane: (2011)

Omalizumab and IgE in the Control of Severe Allergic Asthma
od: Yasuhiro Gon, i wsp.
Wydane: (2022-03-01)

The rationale for treating allergic asthma with anti-IgE
od: E. Hamelmann
Wydane: (2007-09-01)

Evidence of infectious asthma phenotype: Chlamydia-induced allergy and pathogen-specific IgE in a neonatal mouse model.
od: Katir K Patel, i wsp.
Wydane: (2013-01-01)

Development and comparison of different versions of ELISA for detection of specific IgE-antibodies
od: O. Galkin, i wsp.
Wydane: (2016-11-01)

Characterization of Specific IgE Antibody Related to Antigen 5 of Echinococcus granulosus
od: AR Khabiri, i wsp.
Wydane: (2007-05-01)

Characterization of Specific IgE Antibody Related to Antigen 5 of Echinococcus granulosus
od: AR Khabiri, i wsp.
Wydane: (2007-03-01)

Recombinant soluble form of the high-affinity IgE receptor α subunit and anti-IgE antibody inhibit IgE synthesis by IgE-expressing B cells through distinct pathways
od: Keiichi Kajiwara, i wsp.
Wydane: (2002-01-01)

Association between specific IgE to staphylococcal enterotoxin B and the eosinophilic phenotype of asthma
od: Soyoon Sim, i wsp.
Wydane: (2024-07-01)

The use of machine learning to understand the relationship between IgE to specific allergens and asthma.
od: Thomas A E Platts-Mills, i wsp.
Wydane: (2018-11-01)

Omalizumab in the management of patients with allergic (IgE-mediated) asthma
od: Thomas Sandstr&ouml;m
Wydane: (2009-05-01)

The prevalence and identity of <it>Chlamydia</it>-specific IgE in children with asthma and other chronic respiratory symptoms
od: Patel Katir K, i wsp.
Wydane: (2012-04-01)

IgE/IgG1 antibody responses to ubiquitin are associated with emergency room attendance due to asthma symptoms
od: Juan Felipe López-Crespo, i wsp.
Wydane: (2018-06-01)

Evaluation of a Novel Detection Method for Allergen-Specific IgE Antibodies with IgE Receptor Crosslinking Using Rat Food Allergy Model
od: Soichiro Ishii, i wsp.
Wydane: (2024-08-01)

Multiplex Specific IgE Profiling in Neonatal Stool of Preterms Predicts IgE-Mediated Disease
od: Youssouf Sereme, i wsp.
Wydane: (2023-02-01)

Correlation of symptoms with total IgE and specific IgE levels in patients presenting with allergic rhinitis
od: Rifat Karli, i wsp.
Wydane: (2013-04-01)

ANTI-IgE THERAPY — BREAKTHROUGH IN TREATMENT FOR BRONCHIAL ASTHMA
od: article editorial
Wydane: (2007-06-01)

ANTI-IgE THERAPY — BREAKTHROUGH IN TREATMENT FOR BRONCHIAL ASTHMA
od: article editorial
Wydane: (2007-06-01)